Ticker Details
ADC Therapeutics SA
IPO Date:	May 18, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$477.69M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 3.75%
Avg Daily Range (30 D):	$0.12 | 2.89%
Avg Daily Range (90 D):	$0.13 | 3.19%

Institutional Daily Volume
Avg Daily Volume:	.46M
Avg Daily Volume (30 D):	.69M
Avg Daily Volume (90 D):	.89M

Trade Size
Avg Trade Size (Sh.):	140
Avg Trade Size (Sh.) (30 D):	100
Avg Trade Size (Sh.) (90 D):	118

Institutional Trades
Total Institutional Trades:	339
Avg Institutional Trade:	$1.37M
Avg Institutional Trade (30 D):	$1.22M
Avg Institutional Trade (90 D):	$1.61M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.02M
Avg Closing Trade (30 D):	$1.2M
Avg Closing Trade (90 D):	$1.53M
Avg Closing Volume:	459.39K

News

Jan 13, 2026 @ 9:58 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 30, 2025 @ 5:59 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 30, 2025 @ 5:50 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Jun 26, 2025 @ 3:44 PM The $900 Billion Question: Who Will Deliver the Ne... Source: Prnewswire

May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.12	$.02	$-1.12
Diluted EPS	$-1.12	$.02	$-1.12
Revenue	$81.36M	$23.06M	$81.36M
Gross Profit	$75.56M		$75.56M
Net Income / Loss	$-142.62M	$-6.41M	$-142.62M
Operating Income / Loss	$-121.5M	$-17.92M	$-121.5M
Cost of Revenue	$5.8M		$5.8M
Net Cash Flow	$10.47M	$26.6M	$10.47M
PE Ratio

Splits
May 10, 2005	1:7